Copyright
©The Author(s) 2025.
World J Clin Oncol. Aug 24, 2025; 16(8): 107778
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107778
Published online Aug 24, 2025. doi: 10.5306/wjco.v16.i8.107778
Figure 1 The other raw unpublished images.
A: Positive control for pS9GSK-3β showing strong membranous expression in normal urothelium (replace figure 3A, a); B: Cyclin D1 nuclear immunoexpression in 60%-70% (replace figure 3B, h); C: 100% nuclear staining for Cyclin D1 in urothelium (replace figure 3C, m).
- Citation: Maurya N, Singh R, Goel A, Singhai A, Singh UP, Agrawal V, Garg M. Correction to “Clinicohistopathological implications of phosphoserine 9 glycogen synthase kinase-3β/ β-catenin in urinary bladder cancer patients”. World J Clin Oncol 2025; 16(8): 107778
- URL: https://www.wjgnet.com/2218-4333/full/v16/i8/107778.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i8.107778